The identification of the link between CRL4 and the Hippo pathway during the transition between NSC quiescence and reactivation could potentially open new strategies for the treatment of neurodevelopmental disorders by targeting the components of the Hippo pathway. Here, IL17RB is linked to neurodevelopmental disorder.